Blue Owl Capital Q2 Earnings Call Highlights

Blue Owl Capital reported second-quarter 2026 adjusted net investment income of $0.34 per share, up from $0.31 in the prior quarter, as a large investment realization and higher specialty-finance dividend income lifted results. Net asset value per share declined to $14.26 from $14.41 in the first quarter, primarily due to a markdown on one portfolio company. Chief Executive Officer Craig Packer said adjusted net investment income translated to a 9.6% annualized return on equity, more than 100 basis points above the prior quarter. The company said earnings comfortably covered its base dividend and supported a supplemental distribution. The board declared a third-quarter base dividend of $0.31 per share, payable Oct. 15 to shareholders of record Sept. 30. It also declared a $0.02 per-share supplemental dividend, payable Sept. 15 to shareholders of record Aug. 31. Management attributed much of the quarter-over-quarter increase in net investment income to the repayment of its preferred-equity investment in Mavis Tire. Blue Owl collected approximately $274 million in cash from the repayment, including $66 million of accrued payment-in-kind, or PIK, interest. The investment generated a 1.5-times multiple on invested capital, according to Senior Managing Director Logan Nicholson. The Mavis repayment was Blue Owl’s largest PIK investment realization to date and contributed about $0.03 per share of fee income, management said during the question-and-answer session. Chief Financial Officer and Chief Operating Officer Jonathan Lamm said the income was recorded as fee income because of the way the preferred instrument was repurchased, rather than as interest income. Nicholson said Mavis had grown to roughly four times its size since Blue Owl’s initial preferred-equity investment and had become one of the country’s largest tire-service companies. The realization reduced PIK income to 10.7% of total investment income in the second quarter, compared with peak levels above 13% two years earlier. Nicholson said much of Blue Owl’s PIK exposure was intentionally structured at investment inception to enhance returns rather than resulting from distressed borrowers. Higher dividend income from the company’s life sciences-focused specialty finance vehicle, LSI, also contributed to quarterly earnings. LSI benefited from the repayment of ITM Radiopharma, which generated an internal rate of return above 20% on a $140 million position, Nicholson said. Since inception, LSI has generated returns of more than 15% to Blue Owl, according to management. Blue Owl funded $429 million of investments during the second quarter and received $747 million of repayments. The imbalance reduced net leverage to 1.11 times, the company’s lowest level in more than two years and within its target range of 0.9 to 1.25 times. Management said transaction ac...